Health Canada
- Status: approved
long acting injectable risperidone, Conventional Dose Group (long acting injectable risperidone, Conventional Dose Group) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Northwestern University is the originator. The local marketing authorisation holder may differ — check the official source linked above.